US Neurological Disorder Drugs Market Size, Industry Trends, Share and Forecast 2020-2026
The US neurological disorder drugs market is anticipated to grow significantly over the forecast period (2020-2026). Rising cases of neurological disorders, geriatric population, and rapid advancement by the key players operating in the neurological disorder drugs landscape are some of the key factors that drive the growth of the US neurological disorder drugs industry.
Besides, frequent
developments in healthcare and drug discovery are leading to the introduction
of new drugs for the treatment of neurological diseases. Key authorities such
as WHO, National Institutes of Health, and National Institute of Neurological
Disorders and Stroke are taking productive steps that flares-up the research
activities for the novel drug discovery. For instance, in August 2019, the
National Center for Advancing Translational Sciences and National Institute of
Neurological Disorders and Stroke invited researchers to conduct a study on
rare neurological and neuromuscular disorders.
To
Request a Sample of our Report on US
Neurological Disorder Drugs Market: https://www.omrglobal.com/request-sample/us-neurological-disorder-drugs-market
Besides the presence of the key players such as Eli
Lilly and Co., Merck & Co. Inc., and Pfizer Inc. are contributing to the
growth of the US neurological disorder drugs market growth. Further, the
well-established healthcare infrastructure and a significant rise in the
population with the age group ranging between 18 and 64 are also driving the
market growth. For instance, as per the US Census Bureau, the total population
in the US was more than 325.7 million, of which 62% was constituted by 18-64
age group people.
Market Coverage
·
Market number available for – 2019-2026
·
Base year- 2019
·
Forecast period- 2020-2026
·
Segment Covered- By Disorder Type
·
Country Covered- US
·
Competitive Landscape- Eli Lilly and Co., Merck
& Co. Inc., Abbvie Inc., Apotex Inc., AstraZeneca Plc, Pfizer Inc., Biogen
Inc., and Amgen Inc.
Key questions addressed by the report
·
What is the market growth rate?
·
Which segment dominates the market in the base
year?
·
Which segment will project the fastest growth in
the market?
·
How COVID-19 impacted the market?
·
Recovery Timeline
·
Deviation from the pre-COVID-19 forecast
·
Most affected segment
·
Who is the leader in the market?
·
How players are addressing challenges to sustain
growth?
·
Where is the investment opportunity?
(Get 15% Discount on Buying this Report)
A full
Report of US Neurological Disorder Drugs Market is Available at: https://www.omrglobal.com/industry-reports/us-neurological-disorder-drugs-market
US Neurological Disorder Drugs Market –
Segmentation
By Disorder Type
·
Alzheimer’s Disease
·
Parkinson’s Disease
·
Multiple Sclerosis
·
Huntington Disease
·
Others
Company Profiles
·
AbbVie Inc.
·
ACADIA Pharmaceuticals Inc.
·
ApotexInc.
·
Allergan Plc
·
Amgen Inc.
·
AstraZeneca Plc
·
Biogen Inc.
·
Eli Lilly and Co.
·
Merck & Co. Inc.
·
Pfizer Inc.
Reasons
to buy from us –
1.
We cover more than 15 major industries, further segmented into more than 90
sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-neurological-disorder-drugs-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion
Market Research
Contact Person: Mr.
Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment